“We have served the FDA on over 30 initiatives,” McKinsey wrote in winning $1.1 million in contracts to advise the agency’s Center for Tobacco Products. McKinsey’s tasks included “risk identification and mitigation” as well as “influencing the behaviors, opinions, and practices that are contrary to the goals and objectives” of tobacco regulators. Presumably, that included McKinsey’s cigarette clients.
